Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PL-3994 in mild to moderate asthma
NCT01304628Phase 2Withdrawn
- Sponsor
- Palatin Technologies, Inc.
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PL-3994 in asthma, sponsored by Palatin Technologies, Inc.. Status: withdrawn.
02
Drugs
PL-3994
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01304628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304628.